Form D · Biotechnology
Love Lifesciences LLC
Overland Park, KS · CIK 0001940540
Offering snapshot reported Nov 23, 2022 · SEC filing
- Reported sold
- $275K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2022 | Initial | $275,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465678
Source: Form D, filed Nov 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Hopper | Executive |
| Nicholas Love | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6724 W 72 Nd St
Overland Park, KS, 66204
Overland Park, KS, 66204